Human monoclonal antibodies that react w
โ
Darren J. Schofield; Birke Bartosch; Yohko K. Shimizu; Tobias Allander; Harvey J
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 187 KB
Active and/or passive immunoprophylaxis against hepatitis C virus (HCV) remain unachieved goals. Monoclonal antibodies might provide one approach to protection. We derived human monoclonal antibodies from the bone marrow of a patient with a well-controlled HCV infection of 22 years duration. Five di